Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
J Immunol Res. 2018;2018:2912671
Authors: Barros MR, de Oliveira THA, de Melo CML, Venuti A, de Freitas AC
Abstract
The modulation of the host innate immune system is a well-established carcinogenesis feature of several tumors, including human papillomavirus- (HPV-) related cancers. This virus is able to interrupt the initial events of the immune response, including the expression of Toll-like receptors (TLRs), cytokines, and inflammation. Both TLRs and cytokines play a central role in HPV recognition, cell maturation and differentiation as well as immune signalling. Therefore, the imbalance of this sensitive control of the immune response is a key factor for developing immunotherapies, which strengthen the host immune system to accomplish an efficient defence against HPV and HPV-infected cells. Based on this, the review is aimed at exposing the HPV immune evasion mechanisms involving TLRs and cytokines and at discussing existing and potential immunotherapeutic TLR- and cytokine-related tools.
PMID: 29854832 [PubMed - in process]
Source: Journal of Immunology Research - Category: Allergy & Immunology Tags: J Immunol Res Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Genital Warts | Human Papillomavirus (HPV) | Immunotherapy